Montelukast for the treatment of asthma in the adult population (Q37903337)

25 August 2017

1 reference

title

Montelukast for the treatment of asthma in the adult population (English)

1 reference

25 August 2017

0 references

Salima Amlani

1

1 reference

25 August 2017

Thanu Nadarajah

series ordinal

2

1 reference

25 August 2017

Richard Andrew McIvor

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

22 July 2011

1 reference

Expert Opinion on Pharmacotherapy

25 August 2017

published in

1 reference

25 August 2017

volume

12

1 reference

25 August 2017

issue

13

1 reference

25 August 2017

page(s)

2119-2128

1 reference

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

The global burden of asthma: executive summary of the GINA Dissemination Committee report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Allergic rhinitis and asthma: the link, the new ARIA classification and global approaches to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Rhinitis as an independent risk factor for adult-onset asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Global strategy for asthma management and prevention: GINA executive summary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Tiotropium bromide step-up therapy for adults with uncontrolled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Asthma control during the year after bronchial thermoplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Montelukast in pediatric asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Potential masking effects of salmeterol on airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

United airways disease: therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Real-life asthma care in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Evaluation of 3-5 months' add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Antileukotriene drugs: clinical application, effectiveness and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Churg-Strauss Syndrome in Patients Receiving Montelukast as Treatment for Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Montelukast in the treatment of asthma and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Suicidality and montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Utility of exhaled nitric oxide in the diagnosis and management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.600689

10.1517/14656566.2011.600689

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference